U.S. Markets open in 2 hrs 16 mins
  • S&P Futures

    3,621.25
    -15.25 (-0.42%)
     
  • Dow Futures

    29,692.00
    -182.00 (-0.61%)
     
  • Nasdaq Futures

    12,258.50
    +1.00 (+0.01%)
     
  • Russell 2000 Futures

    1,840.80
    -12.20 (-0.66%)
     
  • Crude Oil

    44.92
    -0.61 (-1.34%)
     
  • Gold

    1,774.80
    -13.30 (-0.74%)
     
  • Silver

    22.25
    -0.38 (-1.70%)
     
  • EUR/USD

    1.1989
    +0.0019 (+0.1559%)
     
  • 10-Yr Bond

    0.8420
    0.0000 (0.00%)
     
  • Vix

    22.33
    +1.08 (+5.08%)
     
  • GBP/USD

    1.3351
    +0.0037 (+0.2750%)
     
  • USD/JPY

    104.0900
    +0.0050 (+0.0048%)
     
  • BTC-USD

    18,684.70
    +333.25 (+1.82%)
     
  • CMC Crypto 200

    367.77
    +30.27 (+8.97%)
     
  • FTSE 100

    6,358.52
    -9.06 (-0.14%)
     
  • Nikkei 225

    26,433.62
    -211.09 (-0.79%)
     

Esperion Therapeutics: 3Q Earnings Snapshot

·1 min read

ANN ARBOR, Mich. (AP) _ Esperion Therapeutics Inc. (ESPR) on Monday reported a loss of $85.4 million in its third quarter.

The Ann Arbor, Michigan-based company said it had a loss of $3.07 per share.

The results exceeded Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of $3.52 per share.

The biopharmaceutical company posted revenue of $3.8 million in the period, also topping Street forecasts. Four analysts surveyed by Zacks expected $3.7 million.

Esperion Therapeutics shares have dropped 51% since the beginning of the year. In the final minutes of trading on Monday, shares hit $29.09, a fall of 27% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ESPR at https://www.zacks.com/ap/ESPR